Moneycontrol
Get App
you are here: HomeNewsBusiness
Last Updated : Aug 13, 2019 10:46 AM IST | Source: PTI

Unichem Lab gets USFDA nod for pain management drug

The company has received abbreviated new drug application (ANDA) approval from the US Food and Drug Administration (USFDA) for Unichem's Tramadol Hydrochloride tablets USP, in the strength 50 mg, Unichem Laboratories said in a regulatory filing on Tuesday.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Drug firm Unichem Laboratories has received approval from the US health regulator to market pain management drug Tramadol Hydrochloride tablets.

The company has received abbreviated new drug application (ANDA) approval from the US Food and Drug Administration (USFDA) for Unichem's Tramadol Hydrochloride tablets USP, in the strength 50 mg, Unichem Laboratories said in a regulatory filing on Tuesday.

The approved product is a generic version of Ultram tablets, 50 mg, of Janssen Pharmaceuticals, Inc.

Close

Tramadol Hydrochloride tablets are indicated for use in adults for the management of pain severe enough to require an opioid analgesic, and for which alternative treatments are inadequate.

Unichem said the product will be commercialised from its Ghaziabad, Uttar Pradesh, plant.

Shares of Unichem Laboratories were trading 1.35 per cent lower at Rs 175.60 apiece on the BSE.

Subscribe to Moneycontrol Pro and gain access to curated markets data, trading recommendations, equity analysis, investment ideas, insights from market gurus and much more. Get Moneycontrol PRO for 1 year at price of 3 months at 289. Use code FREEDOM.
First Published on Aug 13, 2019 10:43 am
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant